Psoriasis
Conditions
Interventions
A survey will be conducted on 60 people of both sexes.
The products will be applied as it is on semi-occlusive dressings, with the aid of 1 mL disposable syringe. Distilled water will be used as a con
Sponsors
TCI BIOTECNOLOGIA LTDA
TCI BIOTECNOLOGIA LTDA
Eligibility
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: Male and female; Age: 18 to 59 years; Phototype: I to IV; Whole skin of the area;
Exclusion criteria
Exclusion criteria: Participants who refuse to participate in the study; Skin marks in the experimental area that interfere in the evaluation of possible skin reactions; Active dermatoses (local and disseminated) that may interfere with the results of the study; Pregnant or lactating women; Historic of allergic reactions, irritation or intense feelings of discomfort to topical products: cosmetics and medicines; Volunteers with a history of allergy to the material used in the study; Background of atopy; Use of vaginal cream; Participants with a history of allergy to products in the tested category; Recent gynecological surgeries; Discharges; History of pathologies aggravated or triggered by ultraviolet radiation; Immunodeficiency sufferers; Kidney, heart or liver transplantation; Forecast of intense sun exposure or tanning session during the period of the study; Forecast of bathing in the sea, pool or sauna during the study; Participants who practice water sports; Use of the following medications for systemic topical use: immunosuppressants, antihistamines, non-hormonal anti-inflammatory drugs, and corticosteroids up to two weeks before selection; Treatment with acidic vitamin A and / or its derivatives orally or topically up to 01 month before the beginning of the study; Vaccination forecast during the study or up to 03 weeks before the study; Any condition not mentioned above that, in the opinion of the investigator, could compromise the evaluation of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to prove, trought the patch test, the absence of primary skin irritation reactions and accumulated and allergic reactions by sensitization by investigative products, if no participant reports/presents discomfort sensations/clinical signs. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is hoped to guarantee the safety of the products to the community, through the patch test, if no participant reports/presents discomfort sensations/clinical signs. | — |
Countries
Brazil
Contacts
Public ContactCassiano Escudeiro
Outcome results
None listed